You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API IRBESARTAN


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing IRBESARTAN

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Sanofi-Aventis US LLC AVAPRO irbesartan 0024-5850 CARNAUBA WAX
Sanofi-Aventis US LLC AVAPRO irbesartan 0024-5850 CELLULOSE, MICROCRYSTALLINE
Sanofi-Aventis US LLC AVAPRO irbesartan 0024-5850 CROSCARMELLOSE SODIUM
Sanofi-Aventis US LLC AVAPRO irbesartan 0024-5850 HYPROMELLOSE
Sanofi-Aventis US LLC AVAPRO irbesartan 0024-5850 LACTOSE MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing IRBESARTAN

Company Ingredient NDC Excipient
Unichem Pharmaceuticals (USA) Inc irbesartan 29300-212 CROSCARMELLOSE SODIUM
Unichem Pharmaceuticals (USA) Inc irbesartan 29300-212 MAGNESIUM STEARATE
Unichem Pharmaceuticals (USA) Inc irbesartan 29300-212 MANNITOL
Unichem Pharmaceuticals (USA) Inc irbesartan 29300-212 POLOXAMER 188
Unichem Pharmaceuticals (USA) Inc irbesartan 29300-212 SILICON DIOXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for IRBESARTAN

Excipient focus: CALCIUM STEARATE

Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: FERRIC OXIDE RED

IRBESARTAN drug variants containing FERRIC OXIDE RED

Company Ingredient NDC
sanofi-aventis US LLC irbesartan and hydrochlorothiazide 0024-5855
West-Ward Pharmaceuticals Corp irbesartan and hydrochlorothiazide 0054-0254
Teva Pharmaceuticals USA Inc irbesartan and hydrochlorothiazide 0093-8238
Winthrop US a business of sanofi-aventis US LLC irbesartan and hydrochlorothiazide 0955-1045
Unichem Pharmaceuticals (USA) Inc irbesartan and hydrochlorothiazide 29300-215
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: FERRIC OXIDE YELLOW

IRBESARTAN drug variants containing FERRIC OXIDE YELLOW

Company Ingredient NDC
sanofi-aventis US LLC irbesartan and hydrochlorothiazide 0024-5855
West-Ward Pharmaceuticals Corp irbesartan and hydrochlorothiazide 0054-0254
Teva Pharmaceuticals USA Inc irbesartan and hydrochlorothiazide 0093-8238
Winthrop US a business of sanofi-aventis US LLC irbesartan and hydrochlorothiazide 0955-1045
Unichem Pharmaceuticals (USA) Inc irbesartan and hydrochlorothiazide 29300-215
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: POLOXAMER 188

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 300

Excipient focus: POLYETHYLENE GLYCOL 3000

Excipient focus: POLYETHYLENE GLYCOL 3350

IRBESARTAN drug variants containing POLYETHYLENE GLYCOL 3350

Company Ingredient NDC
Unichem Pharmaceuticals (USA) Inc irbesartan and hydrochlorothiazide 29300-215
Hisun Pharmaceuticals USA Inc irbesartan and hydrochlorothiazide 42658-141
Solco Healthcare US LLC irbesartan and hydrochlorothiazide 43547-330
LUPIN LIMITED irbesartan and hydrochlorothiazide 57297-413
Lupin Pharmaceuticals Inc irbesartan and hydrochlorothiazide 68180-413
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K25

Excipient focus: POVIDONE K29/32

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group